CITIC FAMC (02799): He Jinsong nominated as Executive Director and Chairman

19:03 17/08/2026

CITIC Financial Assets (02799) announced that Mr. He Jinsong has been nominated as the executive director and chairman of the company, approved at the board meeting held on August 17, 2026. Mr. He's term as executive director will commence upon approval by the company's shareholders' meeting and the National Financial Supervisory Administration, lasting for three years, with the possibility of re-election upon term expiration. After approval by the National Financial Supervisory Administration, Mr. He's term as chairman will align with his term as director. Additionally, in accordance with the relevant provisions of the company's articles of association, Mr. He will serve as the chairman of the Board's Strategic Development Committee during his tenure as chairman.

CITIC FAMC (02799) announced that at the board meeting held on August 17, 2026, Mr. He Jinsong was nominated as the executive director and chairman of the company. Mr. He's term as executive director will commence upon approval by the company's shareholders and the China National Financial Regulatory Administration, with a term of three years, and he may be re-elected upon the expiration of his term. Upon approval by the China National Financial Regulatory Administration, Mr. He's term as chairman will be consistent with his term as director. Furthermore, according to relevant provisions of the company's articles of association, during his tenure as chairman, Mr. He will serve as the chairman of the board's Strategic Development Committee.

GUOTAI JUNAN I (01788) has appointed Haode Financing as its independent financial advisor.

HAIXI PHARMA (02637): HX9428 has been granted Fast Track designation by the U.S. FDA for the treatment of neovascular age-related macular degeneration.

Preview of US Stock Market | The three major stock index futures were mixed, with chip and optical communication stocks seeing a widespread rise before the market opened. U.S. stocks are entering "Retail Earnings Week."

GUOTAI JUNAN I (01788) has appointed Haode Financing as its independent financial advisor.

HAIXI PHARMA (02637): HX9428 has been granted Fast Track designation by the U.S. FDA for the treatment of neovascular age-related macular degeneration.